
News and disclosures filtered by period, publisher, and event group.
These categories classify available headlines for faster review and are not an official legal taxonomy.
Select a headline to open the full news page in the app.
Toronto, Ontario – May 27, 2026 - TheNewswire – NeuroThera Labs Inc. (TSXV: NTLX) (the " Company " or " NeuroThera "), a clinical-stage biotech company and a majority-owned subsidiary of SciSparc Ltd. (Nasdaq: SPRC), is providing the following update with respect to its previously announced proposed acquisition (the " Transaction ") of approximately 54.01% of the issued and outstanding ordinary shares (the “ Purchased Shares ”) of CliniQuantum Ltd. (" CliniQuantum "), as initially announced by news release dated March 10, 2026. The Company is providing this news release to supplement the disclosure contained in its March 10, 2026 news release, including in respect of (i) the license agreement between CliniQuantum and Quantum X Labs Ltd., (ii) the basis for the consideration payable under the Transaction and the fairness opinion received by the Company's board of directors, (iii) certain amendments to the share purchase agreement dated March 9, 2026 (the “ SPA ”) between the Company, CliniQuantum and the holders of the Purchased Shares (the “ Selling Shareholders ”), including the establishment of a floor price for future share issuances, an extension of the outside date, and the execution of lock-up arrangements by the Selling Shareholders as a condition of closing.

Tel Aviv, Israel, April 30, 2026 (GLOBE NEWSWIRE) -- Quantum X Labs Inc. (Nasdaq: QXL) ("Quantum X" or the "Company"), an advanced technologies company (formerly known as Viewbix Inc. (Nasdaq: VBIX)), to commence trading today under new name and new Nasdaq symbol, following a comprehensive corporate rebranding.

Tel Aviv, Israel, April 21, 2026 (GLOBE NEWSWIRE) -- Viewbix Inc. (Nasdaq: VBIX) ("Viewbix" or the "Company"), an advanced technologies company, today announced a comprehensive corporate rebranding to Quantum X Labs Inc. ("Quantum X Labs"). The rebranding represents the Company's evolution toward a leading company that develops and owns quantum computing technology as well as a quantum error correction solution, quantum simulations and quantum sensing technologies, while continuing its legacy digital advertising activities as a business segment.

Tel Aviv, Israel, April 21, 2026 (GLOBE NEWSWIRE) -- Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), an advanced technologies company, today announced a comprehensive corporate rebranding to Quantum X Labs Inc. (“Quantum X Labs”). The rebranding represents the Company's evolution toward a leading company that develops and owns quantum computing technology as well as a quantum error correction solution, quantum simulations and quantum sensing technologies, while continuing its legacy digital advertising activities as a business segment.

Tel Aviv, Israel, March 30, 2026 (GLOBE NEWSWIRE) -- Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), an advanced technologies company, today announced that Nuclear Quantum, a portfolio company of its wholly-owned subsidiary, Quantum X Labs Ltd. (“Quantum X Labs”), has achieved a strategic milestone.

Tel Aviv, Israel, March 20, 2026 (GLOBE NEWSWIRE) -- Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), an advanced technologies company, today announced that its fully-owned subsidiary, Quantum X Labs Ltd. (“Quantum X Labs”), has filed a provisional patent application with the U.S. Patent and Trademark Office (USPTO) for a novel nuclear magnetic resonance (NMR) gyroscope hardware architecture designed to deliver ultra-high precision rotational sensing at significantly lower cost than existing solutions.

Moonage Media reviews the emerging quantum sector in the capital markets following Viewbix's acquisition of Quantum X Labs HONG KONG, March 19, 2026 /PRNewswire/ -- In the rapidly evolving quantum technology landscape, where giants like IBM and Google dominate headlines with massive R&D investments and breakthroughs in scalable quantum computing, smaller players are quietly carving out specialized niches. On March 4, 2026, Viewbix Inc. (NASDAQ: VBIX) completed its strategic acquisition of Quantum X Labs Ltd.
